Pacific Biosciences of Ca... (PACB)
NASDAQ: PACB
· Real-Time Price · USD
1.29
0.06 (4.88%)
At close: Aug 15, 2025, 12:20 PM
Pacific Biosciences of California Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 39.77M | 37.15M | 39.22M | 39.97M | 36.01M | 38.81M | 58.36M | 55.69M | 47.57M | 38.9M | 27.35M | 32.31M | 35.47M | 33.17M | 36.02M | 34.89M | 30.61M | 29M |
Cost of Revenue | 25.08M | 400.57M | 29.17M | 29.96M | 30.07M | 27.53M | 48.79M | 37.79M | 32.03M | 29.14M | 22.21M | 18.76M | 19.27M | 19.02M | 19.25M | 19.52M | 16.86M | 16.02M |
Gross Profit | 14.68M | -363.41M | 10.06M | 10M | 5.94M | 11.28M | 9.57M | 17.9M | 15.55M | 9.76M | 5.14M | 13.55M | 16.19M | 14.15M | 16.77M | 15.36M | 13.75M | 12.98M |
Operating Income | -44.02M | -402.6M | -153.03M | -64.08M | -175.85M | -81.36M | -87.55M | -82.49M | -73.17M | -91.25M | -82.49M | -70.34M | -67.97M | -78.59M | -64.68M | -74.48M | -37.57M | -33.71M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -41.9M | -426.38M | 2.69M | -60.73M | -173.32M | -78.18M | -82.74M | -77.58M | -69.83M | -88.02M | -84.38M | -76.97M | -71.39M | -81.5M | -68.15M | -78.28M | -41M | -87.44M |
Net Income | -41.93M | -426.07M | 2.37M | -60.73M | -173.32M | -78.18M | -82.02M | -66.87M | -69.83M | -81.15M | -79.84M | -83.6M | -71.39M | -84.41M | -69.33M | 16.54M | -41M | -87.44M |
Selling & General & Admin | 36.17M | 40.17M | 41.15M | 43.75M | 35.72M | 42.41M | 46M | 43.43M | 40.57M | 39.82M | 45M | 36.8M | 39.25M | 39.8M | 37.32M | 31.61M | 29.06M | 26.14M |
Research & Development | 22.53M | 29.05M | 27.47M | 25.52M | 38.48M | 43.45M | 44.54M | 47.51M | 46.17M | 48.94M | 42.62M | 47.09M | 50.35M | 52.94M | 42.58M | 27.51M | 22.27M | 20.55M |
Other Expenses | n/a | 366.75M | 94.47M | n/a | 107.58M | 6.78M | 6.58M | 9.45M | 1.98M | n/a | n/a | n/a | 256K | -279K | 1K | -133K | 161K | 64K |
Operating Expenses | 58.7M | 435.98M | 163.09M | 69.26M | 181.78M | 92.64M | 97.12M | 100.39M | 88.72M | 88.76M | 87.63M | 83.89M | 89.6M | 92.74M | 79.9M | 59.11M | 51.33M | 46.69M |
Interest Expense | 1.74M | 1.74M | 2.76M | 3.54M | 3.54M | 3.58M | 3.57M | 3.59M | 3.55M | 3.63M | 3.65M | 3.66M | 3.68M | 3.7M | 3.48M | 3.67M | 3.59M | 1.79M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 83.79M | 466.09M | 192.25M | 104.04M | 211.86M | 120.17M | 145.91M | 138.18M | 120.75M | 117.9M | 109.84M | 102.65M | 108.87M | 111.76M | 99.15M | 78.64M | 68.18M | 62.71M |
Income Tax Expense | 35K | -302K | 316K | n/a | n/a | n/a | -718K | -10.71M | n/a | -6.87M | -4.54M | 6.63M | -330K | 2.91M | 1.18M | -94.82M | n/a | -543K |
Shares Outstanding (Basic) | 300.16M | 296.86M | 283M | 272.92M | 272.38M | 269.58M | 264.86M | 255M | 249.4M | 242.03M | 226.24M | 225.12M | 224.5M | 220.27M | 217.08M | 202.19M | 195.24M | 194.3M |
Shares Outstanding (Diluted) | 300.16M | 296.86M | 306.89M | 272.92M | 272.38M | 269.58M | 267.12M | 255M | 250.07M | 242.03M | 226.24M | 225.12M | 224.5M | 222.29M | 220.73M | 215.13M | 198.57M | 194.79M |
EPS (Basic) | -0.14 | -1.44 | 0.01 | -0.22 | -0.64 | -0.29 | -0.31 | -0.26 | -0.28 | -0.34 | -0.35 | -0.37 | -0.32 | -0.38 | -0.32 | 0.08 | -0.21 | -0.45 |
EPS (Diluted) | -0.14 | -1.44 | 0.01 | -0.22 | -0.64 | -0.29 | -0.31 | -0.26 | -0.28 | -0.34 | -0.35 | -0.37 | -0.32 | -0.38 | -0.31 | 0.08 | -0.21 | -0.45 |
EBITDA | -35.58M | -51.86M | 16.39M | -41.09M | -155.49M | -62.59M | -61.31M | -68.53M | -61.41M | -79.87M | -76.01M | -68.99M | -63.45M | -73.61M | -60.59M | -71.9M | -35.02M | -83.25M |
EBIT | -40.16M | -424.64M | 5.44M | -57.19M | -169.78M | -74.6M | -79.17M | -73.99M | -66.28M | -84.39M | -80.27M | -73.31M | -67.71M | -77.95M | -64.67M | -74.61M | -37.41M | -85.65M |
Depreciation & Amortization | 4.58M | 372.78M | 10.95M | 16.1M | 14.29M | 12.01M | 17.86M | 5.46M | 4.86M | 4.52M | 4.54M | 4.32M | 4.27M | 4.19M | 4.08M | 2.71M | 2.39M | 2.4M |